BLYTZ, INC. – Trademark Portfolio

Entity Type: 03

BLYTZ, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include BLYTZ, BLYTZPAY, TEXT. PAY. DONE., and BANKLESS BILL PAY. The owner is based in DRAPER, UT.

13961 MINUTEMAN DRIVE SUITE 375

DRAPER, UT 84120

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BLYTZ, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (8 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (8 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does BLYTZ, INC. have?

BLYTZ, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending.

What trademark classes does BLYTZ, INC. file in?

BLYTZ, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

What are BLYTZ, INC.'s most well-known trademarks?

BLYTZ, INC.'s registered trademark portfolio includes well-known marks such as BLYTZ, BLYTZPAY, TEXT. PAY. DONE., and BANKLESS BILL PAY. These are among 6 currently registered trademarks in the portfolio.

What is BLYTZ, INC.'s trademark registration success rate?

BLYTZ, INC. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.